HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation

CT Screening for Lung Cancer: Diagnoses Resulting from the New York Early Lung Cancer Action Project¹

¹ The complete list of investigators and affiliations is in the Appendix. From the 2004 RSNA Annual Meeting. Received March 14, 2006; revision requested May 17; revision received June 9; accepted July 7; final version accepted September 1. Supported in part by the City of New York Department of Health and Mental Hygiene; Starr Foundation; Empire Blue Cross and Blue Shield; New York Community Trust; New York State Office of Science, Technology, and Academic Research; the Rogers Family Fund; Weill Medical College of Cornell University; Cornell University; and Academic Medical Development Company. Address correspondence to Claudia I. Henschke, PhD, MD, Department of Radiology, New York Presbyterian Hospital–Weill Cornell Medical Center, 525 E 68th St, New York, NY 10021 (e-mail: chensch{at}med.cornell.edu).

Purpose: To evaluate prospectively the diagnostic performance of the New York Early Lung Cancer Action Project (NY-ELCAP) regimen in the diagnosis of early lung cancer at baseline and annual repeat computed tomographic (CT) screenings.

Materials and Methods: Informed consent and institutional review board approval were obtained for this HIPAA-compliant study of baseline and annual repeat low-dose CT screening performed with a common regimen in asymptomatic individuals at 12 institutions in New York State. All 6295 participants were aged 60 years or older, had smoked for at least 10 pack-years, had no prior cancer, had not undergone chest CT in the previous 3 years, and were medically fit to undergo thoracic surgery. Median age was 66 years, and median smoking history was 40 pack-years. The proportion (and 95% exact confidence intervals [CIs]) of subjects with a positive result, as determined by using nodule size; the diagnoses of lung cancer resulting from subsequent work-up; and the distribution by cancer stage and cell type were determined. When relevant, 95% CIs for the proportions were calculated.

Results: Initial CT imaging led to recommendations for further work-up in 14.4% (95% CI: 13.5%, 15.3%) of the 6295 baseline screenings and 6.0% (95% CI: 5.1%, 6.6%) of the 6014 annual repeat screenings. Of 101 patients in whom the diagnosis of lung cancer resulted from baseline screening and three in whom a diagnosis of lung cancer was prompted by symptoms prior to the first scheduled repeat screening, 95 (91.3%) had no clinical evidence of metastases. Of the 20 patients in whom the diagnosis of lung cancer resulted from annual repeat screening, 17 (85%) showed no evidence of metastases. Of the 134 recommended biopsies, 125 (93.3%) resulted in diagnosis of lung cancer or another malignancy, while none of the 24 biopsies performed outside of the recommendation of the regimen resulted in diagnosis of lung cancer.

Conclusion: The NY-ELCAP regimen of screening revealed that annual CT screening for lung cancer resulted in identification of a high proportion of patients with early-stage disease.

© RSNA, 2007

This article has been cited by other articles:

				G. M. Weiner, K. Schulze, B. Geiger, H. Ebhardt, K.-J. Wolf, and T. Albrecht CT Bronchoscopic Simulation for Guiding Transbronchial Needle Aspiration of Extramural Mediastinal and Hilar Lesions: Initial Clinical Results Radiology, March 1, 2009; 250(3): 923 - 931. [Abstract] [Full Text] [PDF]

				G. Veronesi, M. Bellomi, P. Scanagatta, L. Preda, C. Rampinelli, J. Guarize, G. Pelosi, P. Maisonneuve, F. Leo, P. Solli, et al. Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program J. Thorac. Cardiovasc. Surg., September 1, 2008; 136(3): 611 - 617. [Abstract] [Full Text] [PDF]

				C. M. Park, J. M. Goo, T. J. Kim, H. J. Lee, K. W. Lee, C. H. Lee, Y. T. Kim, K. G. Kim, H. Y. Lee, E.-A. Park, et al. Pulmonary Nodular Ground-Glass Opacities in Patients With Extrapulmonary Cancers: What is Their Clinical Significance and How Can We Determine Whether They Are Malignant or Benign Lesions? Chest, June 1, 2008; 133(6): 1402 - 1409. [Abstract] [Full Text] [PDF]

				J. G. Ravenel, P. Costello, and G. A. Silvestri Screening for Lung Cancer Am. J. Roentgenol., March 1, 2008; 190(3): 755 - 761. [Abstract] [Full Text] [PDF]

				C. I. Henschke and D. F. Yankelevitz CT Screening for Lung Cancer: Update 2007 Oncologist, January 1, 2008; 13(1): 65 - 78. [Abstract] [Full Text] [PDF]